An Effect of Endometrial Cancer Regarding Pathophysiology, Diagnosis and Treatment

Endometrial cancer is a malignancy appearing within the epithelial lining of the uterus. Endometrial cancer is the most prevalent gynecologic malignancy in American women and a significant cause of morbidity and mortality. Over 66,000 new cases were expected in 2023; therefore, clinicians must be equipped with the necessary clinical knowledge to diagnose patients presenting with symptoms namely abnormal uterine bleeding, pelvic pain, or uterine enlargement—common manifestations of this condition. Diagnosing endometrial cancer needs understanding the suggestions particularly for endometrial biopsy, different sampling techniques, and the role of imaging studies in staging and assessing metastases. Managing endometrial cancer comprises surgical staging, adjuvant therapies along with radiation therapy, chemotherapy, hormone therapy, and targeted therapy and post treatment monitoring for recurrence. This course envelops diagnostic techniques, treatment modalities, and post-treatment monitoring for endometrial cancer. The difficult and intricate nature of treating this illness is also acknowledged in this course, emphasizing the value of an interprofessional team approach in improving patient outcomes and reducing the burden of endometrial cancer. Interprofessional collaboration helps participants explore the best ways to care for patients, improve their ability to navigate the complexity of endometrial cancer, and promote treatment through coordinated, all-encompassing efforts across healthcare disciplines.